![Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (inactivated), Annex 3, TRS No 993 Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (inactivated), Annex 3, TRS No 993](https://www.who.int/images/default-source/health-topics/biologicals/vaccine-standardization/annex-3-polio-.tmb-479v.png?Culture=en&sfvrsn=9c854fa9_2)
Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (inactivated), Annex 3, TRS No 993
![Poliomyelitis Prevention in the United States: New Recommendations for Routine Childhood Vaccination Place Greater Reliance on Inactivated Poliovirus Vaccine | Pediatric Annals Poliomyelitis Prevention in the United States: New Recommendations for Routine Childhood Vaccination Place Greater Reliance on Inactivated Poliovirus Vaccine | Pediatric Annals](https://journals.healio.com/cms/asset/57385a01-732d-470b-948f-444b353e7b81/10.3928_00904481-19970601-09-table2.jpg)
Poliomyelitis Prevention in the United States: New Recommendations for Routine Childhood Vaccination Place Greater Reliance on Inactivated Poliovirus Vaccine | Pediatric Annals
![Years in the making: the World Health Organization prequalifies type 2 novel oral polio vaccine | PATH Years in the making: the World Health Organization prequalifies type 2 novel oral polio vaccine | PATH](https://media.path.org/images/nOPV2_50doses_2_2.max-1200x800.jpg)
Years in the making: the World Health Organization prequalifies type 2 novel oral polio vaccine | PATH
Strengthening polio vaccine demand in Ghana: Understanding the factors influencing uptake of the vaccine and the effectiveness of different message frames | PLOS ONE
![Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine | npj Vaccines Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine | npj Vaccines](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41541-021-00325-4/MediaObjects/41541_2021_325_Fig1_HTML.png)
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine | npj Vaccines
![Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) | Semantic Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) | Semantic](https://d3i71xaburhd42.cloudfront.net/5c888623f677b8556e9175d52fb34446f36edd7a/20-Table4-1.png)